Diagnosis and assessment of Crohns disease: The present and the future

Expert Review of Gastroenterology and Hepatology

Volumn 4, Issue 6, 2010, Pages 757-766

  Benevento, Gianluca ^a   Avellini, Claudio ^a   Terrosu, Giovanni ^a   Geraci, Marco ^b   Lodolo, Ilva ^a   Sorrentino, Dario ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

assessment; Crohns disease; diagnosis; mucosal healing; postoperative recurrence; response to treatment

Indexed keywords

C REACTIVE PROTEIN; CALGRANULIN; FLUORODEOXYGLUCOSE F 18; FUNGUS ANTIBODY; INDIUM 111; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ABDOMINAL PAIN; CAPSULE ENDOSCOPY; COLON BIOPSY; COLONOSCOPY; COMPUTED TOMOGRAPHY ENTEROGRAPHY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIARRHEA; ERYTHROCYTE SEDIMENTATION RATE; FECES ANALYSIS; HEMATOCHEZIA; HUMAN; POSITRON EMISSION TOMOGRAPHY; RECURRENT DISEASE; REVIEW; SACCHAROMYCES CEREVISIAE; SENSITIVITY AND SPECIFICITY; SMALL BOWEL ENTEROCLYSIS; SMALL BOWEL FOLLOW THROUGH; SMALL BOWEL MAGNETIC RESONANCE IMAGING; COMPUTER ASSISTED TOMOGRAPHY; DIGESTIVE SYSTEM EXAMINATION; ECHOGRAPHY; GASTROINTESTINAL ENDOSCOPY; MICROBIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

CROHN DISEASE; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; ENDOSCOPY, GASTROINTESTINAL; HUMANS; MAGNETIC RESONANCE IMAGING; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 78649650481     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.10.70     Document Type: Review

References (76)

1. Cosnes J, Cattan S, Blain A et al. Long-term evolution of disease behavior of Crohn's disease. Infamm. Bowel Dis. 8(4), 244-250 (2002).
2. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am. J. Gastroenterol. 105(2), 289-297 (2010).
3. Albert JG, Kotsch J, Köstler W et al. Course of Crohn's disease prior to establishment of the diagnosis. Z. Gastroenterol. 46(2), 187-192 (2008).
4. Nikolaus S, Schreiber S. Diagnostics of infammatory bowel disease. Gastroenterolog y 133(5), 1670-1689 (2007).
5. Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal infammation. Gastroenterology 126(6), 1518-1532 (2004).
6. van Assche G, Dignass A, Panes J et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: defnitions and diagnosis. JCC 4, 7-27 (2010).
7. Ardizzone S, Sarzi Puttini P, Cassinotti A, Bianchi Porro G. Extraintestinal manifestations of infammatory bowel disease. Dig. Liver Dis. 40(S), 253-259 (2008).
8. Ingle SB, Loftus EV Jr. The natural history of perianal Crohn's disease. Dig. Liver Dis. 39(10), 963-969 (2007).
9. Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ. Noninvasive markers in the assessment of intestinal infammation in infammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am. J. Gastroenterol. 103(1), 162-169 (2008).
10. Moscandrew ME, Loftus EV Jr. Diagnostic advances in infammatory bowel disease (imaging and laboratory). Curr. Gastroenterol. Rep. 11(6), 488-495 (2009).
11. Desai D, Faubion WA, Sandborn WJ. Review article: biological activity markers in infammatory bowel disease. Aliment Pharmacol. Ther. 25(3), 247-255 (2007).
12. Vermeire S, van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut 55(3), 426-431 (2006).
13. Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F. Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Infamm. Bowel Dis. 14(1), 32-39 (2008).
14. Dotan I, Fishman S, Dgani Y et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 131(2), 366-378 (2006).
15. Bossuyt X. Serologic markers in infammatory bowel disease. Clin. Chem. 52(2), 171-181 (2006).
16. Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in infammatory bowel disease. Am. J. Gastroenterol. 96(3), 730-734 (2001).
17. Israeli E, Grotto I, Gilburd B et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of infammatory bowel disease. Gut 54(9), 1232-1236 (2005).
18. Li X, Conklin L, Alex P. New serological biomarkers of infammatory bowel disease. World J. Gastroenterol. 14(33), 5115-5124 (2008).
19. Landers CJ, Cohavy O, Misra R et al Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto-and microbial antigens. Gastroenterology 123(3), 689-699 (2002).
20. Dubinsky MC, Kugathasan S, Mei L et al. Increased immune reactivity predicts aggressive complicating Crohn's disease in children. Clin. Gastroenterol. Hepatol 6(10), 1105-1111 (2008).
21. Hommes DW, van Deventer SJ. Endoscopy in infammatory bowel diseases. Gastroenterology 126(6), 1561-1573 (2004).
22. Dorn SD, Abad JF, Panagopoulos G, Korelitz BI. Clinical characteristics of familial versus sporadic Crohn's disease using the Vienna Classifcation. Infamm. Bowel Dis. 10(3), 201-206 (2004).
23. Morson BC, Dawson IMP. Gastrointestinal Pathology. In: Systemic Pathology. Alimentary Tract. Morson BC (Ed.). Blackwell, Churchill Livingstone, Oxford, UK, 203-212 (1979).
24. McHugh JB, Appelman HD, McKenna BJ. The diagnostic value of endoscopic terminal ileum biopsies. Am. J. Gastroenterol. 102(5), 1084-1089 (2007).
25. Geboes K. The strategy for biopsies of the terminal ileum should be evidence based. Am. J. Gastroenterol. 102(5), 1090-1092 (2007).
26. Sankey EA, Dhillon A P, Anthony A et al. Early mucosal changes in Crohn's disease. Gut 34(3), 375-381 (1993).
27. Bernstein CN, Boult IF, Greenberg HM, van der Putten W, Duffy G, Grahame GR. A prospective randomized comparison between small bowel enteroclysis and small bowel follow-through in Crohn's disease. Gastroenterology 113(2), 390-398 (1997).
28. Angriman I, Scarpa M, Ruffolo C et al. Double contrast small-bowel radiography in the preoperative assessment of Crohn's disease: is it still useful? Surg. Today 38(8), 700-704 (2008).
29. Kohli MD, Maglinte DD. CT enteroclysis in small bowel Crohn's disease. Eur. J. Radiol. 69(3), 398-403 (2009).
30. Colombel JF, Solem CA, Sandborn WJ et al. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 55(11), 1561-1567 (2006).
31. Minordi LM, Vecchioli A, Guidi L, Poloni G, Fedeli G, Bonomo L. CT fndings and clinical activity in Crohn's disease. Clin. Imaging 33(2), 123-129 (2009).
32. Siddiki HA, Fidler JL, Fletcher JG et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am. J. Roentgenol. 193(1), 113-121 (2009).
33. Parente F, Greco S, Molteni M, Anderloni A, Bianchi Porro G. Imaging infammatory bowel disease using bowel ultrasound. Eur. J. Gastroenterol. Hepatol. 17(3), 283-291 (2005).
34. Stathaki MI, Koukouraki SI, Karkavitsas NS, Koutroubakis IE. Role of scintigraphy in infammatory bowel disease. World J. Gastroenterol. 15(22), 2693-2700 (2009).
35. Alberini JL, Badran A, Freneaux E et al. Technetium-99m HMPAO-labeled leukocyte imaging compared with endoscopy, ultrasonography, and contrast radiology in children with infammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 32(3), 278-286 (2001).
36. Györke T, Duffek L, Bártfai K et al. The role of nuclear medicine in infammatory bowel disease. A review with experiences of aspecifc bowel activity using immunoscintigraphy with 99mTc anti-granulocyte antibodies. Eur. J. Radiol. 35(3), 183-192 (2000).
37. Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of infammatory diseases using nuclear medicine techniques. Semin. Nucl. Med. 39(2), 124-145 (2009).
38. Holtmann MH, Neurath MF. Anti-TNF strategies in stenosing and fstulizing Crohn's disease. Int. J. Colorectal Dis. 20(1), 1-8 (2005).
39. Albert JG, Martiny F, Krummenerl A et al. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fuoroscopic enteroclysis. Gut 54(12), 1721-1727 (2005).
40. Postgate A, Despott E, Burling D et al. Signifcant small-bowel lesions detected by alternative diagnostic modalities after negative capsule endoscopy. Gastrointest. Endosc. 68(6), 1209-1214 (2008).
41. Leighton JA, Legnani P, Seidman EG. Role of capsule endoscopy in infammatory bowel disease: where we are and where we are going. Infamm. Bowel Dis. 13(3), 331-337 (2007).
42. Siemanowski B, Regueiro M. Management of perianal fstula in Crohn's disease. Infamm. Bowel Dis. 14(Suppl. 2), 266-268 (2008).
43. Vermeire S, Van Assche G, Rutgeerts P. Perianal Crohn's disease: classifcation and clinical evaluation. Dig. Liver Dis. 39(10), 959-962 (2007).
44. Ardizzone S, Maconi G, Cassinotti A, Massari A, Porro GB. Imaging of perianal Crohn's disease. Dig. Liver Dis. 39(10), 970-978 (2007).
45. Ziech M, Felt-Bersma R, Stoker J. Imaging of perianal fstulas. Clin. Gastroenterol. Hepatol. 7(10), 1037-1045 (2009).
46. Griggs L, Schwartz DA. Medical options for treating perianal Crohn's disease. Dig. Liver Dis. 39(10), 979-987 (2007).
47. Bouguen G, Siproudhis L, Bretagne JF, Bigard MA, Peyrin-Biroulet L. Nonfstulizing perianal Crohn's disease: clinical features, epidemiology, and treatment. Infamm. Bowel Dis. 16(8), 1431-1442 (2010).
48. Strong SA. Perianal Crohn's disease. Semin. Pediatr. Surg. 16(3), 185-193 (2007).
49. Felt-Bersma RJ. Endoanal ultrasound in perianal fstulas and abscesses. Dig. Liver Dis. 38(8), 537-543 (2006).
50. Schwartz DA. Imaging and the treatment of Crohn's perianal fstulas: to see is to believe. Am. J. Gastroenterol. 104(12), 2987-2989 (2009).
51. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and effcacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 122(2), 512-530 (2002).
52. Schoepfer AM, Beglinger C, Straumann A et al. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. Am. J. Gastroenterol. 105(1), 162-169 (2010).
53. Esters N, Vermeire S, Joossens S et al. Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am. J. Gastroenterol. 97(6), 1458-1462 (2002).
54. Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Review article: Crohn's disease: monitoring disease activity. Aliment Pharmacol. Ther. 17(Suppl. 2), 11-17 (2003).
55. Kallel L, Ayadi I, Matri S et al. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study. Eur. J. Gastroenterol. Hepatol. 22(3), 340-345 (2010).
56. Fefferman DS, Farrell RJ. Endoscopy in infammatory bowel disease: indications, surveillance, and use in clinical practice. Clin. Gastroenterol. Hepatol. 3(1), 11-24 (2005).
57. Leighton JA, Shen B, Baron TH et al. ASGE guideline: endoscopy in the diagnosis and treatment of infammatory bowel disease. Gastrointest. Endosc. 63(4), 558-565 (2006).
58. Frøslie KF, Jahnsen J, Moum BA, Vatn MH; IBSEN Group. Mucosal healing in infammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 133(2), 412-422 (2007).
59. Baert F, Moortgat L, van Assche G et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 138(2), 463-468 (2010).
60. Sinha R, Murphy P, Hawker P, Sanders S, Rajesh A, Verma R. Role of MRI in Crohn's disease. Clin. Radiol. 64(4), 341-352 (2009).
61. Sempere GA, Martinez Sanjuan V, Medina Chulia E et al. MRI evaluation of infammatory activity in Crohn's disease. AJR Am. J. Roentgenol. 184(6), 1829-1835 (2005).
62. Sachar DB. Recurrence rates in Crohn's disease: predicting the future and predicting the past. Gut 55, 1069-1070 (2006).
63. Sorrentino D, Paviotti A. Postoperative recurrence of Crohn's disease: the beginning of the end? Gastroenterology 137(3), 1181-1182 (2009).
64. Rutgeerts P, Geboes K, Vantrappen G et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 25, 665-672 (1984).
65. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the postoperative course of Crohn's disease. Gastroenterology 99, 956-963 (1990).
66. Lamb CA, Mohiuddin MK, Gicquel J et al. Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease. Br. J. Surg. 96(6), 663-674 (2009).
67. Sorrentino D, Paviotti A, Terrosu G, Avellini C, Geraci M, Zarif D. Low-dose maintenance therapy with infiximab prevents postsurgical recurrence of Crohn's Disease. Clin. Gastroenterol. Hepatol. 8(7), 591-599 (2010).
68. Bourreille A, Jarry M, D'Halluin PN et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn's disease: a prospective study. Gut 55(7), 978-983 (2006).
69. Koilakou S, Sailer J, Peloschek P et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Infamm. Bowel Dis. 16(2), 198-203 (2010).
70. Soyer P, Boudiaf M, Sirol M et al. Suspected anastomotic recurrence of Crohn disease after ileocolic resection: evaluation with CT enteroclysis. Radiology 254(3), 755-764 (2010).
71. Castiglione F, Bucci L, Pesce G et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Infamm. Bowel Dis. 14(9), 1240-1245 (2008).
72. Courville EL, Siegel CA, Vay T, Wilcox AR, Suriawinata AA, Srivastava A. Isolated asymptomatic ileitis does not progress to overt Crohn disease on long-term follow-up despite features of chronicity in ileal biopsies. Am. J. Surg Pathol. 33(9), 1341-1347 (2009).
73. Goldstein NS. Isolated ileal erosions in patients with mildly altered bowel habits. A follow-up study of 28 patients. Am. J. Clin. Pathol. 125(6), 838-846 (2006).
74. Zwas FR, Cirillo NW, el-Serag HB, Eisen RN. Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest. Endosc. 43(5), 463-466 (1996).
75. Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 119(6), 1740-1744 (2000).
76. Rutter MD, Saunders BP, Wilkinson KH et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 130(4), 1030-1038 (2006).